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Abstract
Background: Enteric fever is a major public health problem, causing an estimated 21million new cases and 216,000
or more deaths every year. Current diagnosis of the disease is inadequate. Blood culture only identifies 45 to 70%
of the cases and is time-consuming. Serological tests have very low sensitivity and specificity. Clinical samples
obtained for diagnosis of enteric fever in the field generally have <1 organism/ml of blood, so that even PCR-based
methods, widely used for detection of other infectious diseases, are not a straightforward option in typhoid
diagnosis. We developed a novel method to enrich target bacterial DNA by selective removal of human DNA from
blood samples, enhancing the sensitivity of PCR tests. This method offers the possibility of improving PCR assays
directly using clinical specimens for diagnosis of this globally important infectious disease.
Methods: Blood samples were mixed with ox bile for selective lysis of human blood cells and the released human
DNA was then digested with addition of bile resistant micrococcal nuclease. The intact Salmonella Typhi bacteria
were collected from the specimen by centrifugation and the DNA extracted with QIAamp DNA mini kit. The
presence of Salmonella Typhi bacteria in blood samples was detected by PCR with the fliC-d gene of Salmonella
Typhi as the target.
Results: Micrococcal nuclease retained activity against human blood DNA in the presence of up to 9% ox bile.
Background human DNA was dramatically removed from blood samples through the use of ox bile lysis and
micrococcal nuclease for removal of mammalian DNA. Consequently target Salmonella Typhi DNA was enriched in
DNA preparations and the PCR sensitivity for detection of Salmonella Typhi in spiked blood samples was enhanced
by 1,000 fold.
Conclusions: Use of a combination of selective ox-bile blood cell lysis and removal of human DNA with
micrococcal nuclease significantly improves PCR sensitivity and offers a better option for improved typhoid PCR
assays directly using clinical specimens in diagnosis of this globally important infection disease which we believe
could be of importance in improving clinical care and providing effective evaluation of novel vaccines.
Keywords: Typhoid, Salmonella Typhi, PCR detection
* Correspondence: liqing.zhou@novartis.com
1Oxford Vaccine Centre, Department of Paediatrics, University of Oxford,
Oxford, UK
2Current address: Novartis Vaccines and Diagnostics s.r.l., via Fiorentina 1,
53100, Siena, Italy
© 2012 Zhou and Pollard; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Zhou and Pollard BMC Infectious Diseases 2012, 12:164
http://www.biomedcentral.com/1471-2334/12/164
Background
There are an estimated 21million new cases and 216,000
deaths attributed to typhoid fever every year [1]. The
disease, caused by Salmonella enterica serovar Typhi,
remains a common problem in many parts of the world
where access to clean water is limited. In the regions
where enteric fever is common, clinical diagnosis of ty-
phoid fever is inadequate, as the symptoms it causes are
non-specific and overlap with those of many other
febrile illness including malaria, dengue fever, rickett-
sioses, leptospirosis and melioidosis [2]. Baker et al. has
recently presented the current position in typhoid diag-
nostics, highlighting the need for technological improve-
ments and potential future approaches [3].
The first typhoid diagnostic, the Widal test, was devel-
oped in 1896 and is still widely used. The Widal test is
dependent on agglutination in an assay in which
Salmonella Typhi cells are used to detect antibodies in
blood. Many of the surface antigens of the Enterobacter-
iaceae of which Salmonella Typhi is a member, demon-
strate significant conservation and induce antibodies
that are cross-reactive. Consequently, the Widal test has
very low sensitivity and specificity, and little or no prac-
tical value in endemic areas despite its continued use
[4]. Several other serologically based assays are available
for use in typhoid diagnosis including Typhidot and
Tubex [5,6], but have the same problems associated with
the use of the Widal test. When assessed in population-
based typhoid surveillance studies in several countries
and in all locations Tubex and Typhidot had the
sensitivity and specificity of only around 70% and 80%
respectively [7,8].
Isolation of the causative organism remains the most
reliable diagnostic method in suspected typhoid fever
and blood has been the main sample used for culture of
the organism since 1900 [9,10]. However, blood culture
can only identify 45 to 70% of patients with typhoid
fever, and is highly dependent on the amount of blood
sampled. In addition the bacteraemic level of Salmonella
Typhi, the presence of bactericidal activity in the blood,
recent administration of antibiotics, the type of culture
medium used, and the length of incubation period may
all affect the sensitivity [11,12]. The intracellular nature
of Salmonella serovar Typhi also slows its growth in
blood culture media. One study found that more than
50% of bacterial cells were present intracellularly in the
blood from patients with typhoid fever [11]. In addition,
blood culture facilities are rare in many developing
countries, often limited only to major hospitals in large
cities, making access to blood culture facilities a major
limiting factor in typhoid diagnosis. Furthermore, blood
culture takes at least 2 to 5 days before the identification
of the organism, which is often too late to initiate appro-
priate antibiotic therapy.
Given the problems associated with serological meth-
ods and blood culture, PCR based methods have been
exploited recently because they can theoretically amplify
DNA only from Salmonella Typhi (specificity) and
should detect even low numbers of live or dead bacterial
cells (sensitivity). Many Salmonella Typhi PCR-based
assays have targeted the fliC-d gene, utilizing nested
primers to improve sensitivity [13-18] and reported
excellent sensitivity and specificity when compared to
positive cases (blood culture proven) and healthy con-
trols. However, the number of Salmonella bacteria circu-
lating in the blood of a patient with bacteremia is
generally low with the majority of patients having <1 or-
ganism/ml of blood [19]. This means that the PCR tem-
plate in clinical preparations is dominated by human
DNA and could cause false-positive PCR signals due to
the non-specific binding of primers and false-negative
results due to reduced sensitivity. In practice, the large
excess of human DNA does indeed cause problems for
PCR-based pathogen detection in blood, particularly in
samples with low bacterial numbers [20,21]. Further-
more, small volumes of blood are often used for DNA
extraction or as template in the PCR, which will signifi-
cantly lower the sensitivity of these tests. A DNA or bac-
terial capture system or even a culture enrichment step
prior to amplification may improve molecular sensitivity
of PCR based assays. We have recently reported a fast
and highly sensitive blood culture-PCR method for de-
tection of Salmonella Typhi [22].
From the discussion above it is clear that an optimised
and sensitive assay for PCR diagnosis of typhoid would
work directly on clinical samples, release intracellular
bacteria to improve access to the bacteria DNA, and
finally reduce background human DNA to enrich the
target bacterial DNA. This can be achieved by using a
combination of selective detergents and nucleases. Ox
bile can selectively lyze blood cells, releasing the human
DNA which is accessible to enzymatic degradation. Due
to its bile-resistance, Salmonella Typhi cells remain
intact and are collected by centrifugation for the extrac-
tion of pure Salmonella Typhi DNA. Micrococcal nucle-
ase, derived from Staphylococcus aureus, is a relatively
non-specific endo-exonuclease and can degrade both
DNA and RNA to 3´ phosphomononucleotides and
dinucleotides in the pH range of 7.0-10.0. The enzyme
activity is strictly dependent on Ca2+ and therefore is
easily inactivated by EGTA. We investigated further
micrococcal nuclease activity in ox bile and describe
herein a novel method for the selective enrichment of
Salmonella Typhi DNA from whole blood samples using
ox bile and micrococcal nuclease, which we have termed
“the selective target DNA enrichment method” (STEM).
This method does not require blood culture. By applying
STEM, we could show a great reduction of the human
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background DNA in the DNA preparations from blood
samples, and consequently the sensitivity in PCR detec-
tion of Salmonella Typhi in blood samples is dramatic-




Wild-type Salmonella serovar Typhi Quailes strain,
obtained from the University of Maryland, was used to
spike blood samples in this study. The strain was sub-
cultured in tryptone soya broth (TSB) or on tryptone
soya agar (TSA) (Oxoid, Basingstoke, UK) as needed.
Preparation of spiked blood samples
A colony of overnight culture of Salmonella Typhi
Quailes strain on TSA was inoculated into 2 ml TSB, and
cultured in a 37°C incubator with shaking at 200 revolu-
tions per minute (RPM) for about 2 hours. The culture
was first adjusted to an optical density at 600nm of 0.25
and then prepared for serial 10-fold dilutions in TSB. An
aliquot of 100 μl each of dilutions was plated onto a TSA
plate, and the plates were incubated overnight at 37°C to
determine the colony forming unit (CFU) of Salmonella
Typhi per millilitre. Blood was obtained from healthy
individuals with a sterile syringe and immediately
pipetted into tubes containing heparin. 100 μl each of
the bacterial dilutions was spiked into a 900 μl blood
sample and 200 μl spiked blood samples were used for
DNA isolation.
The blood samples used in the study were obtained
from laboratory volunteers with written informed con-
sent, in accordance with the university policies - Taking
Blood Samples from Colleagues or Students for Research
and Teaching OHS Policy Document 1/03 approved by
the Central University Research Ethics Committee
(CUREC), University of Oxford.
Conventional DNA preparation
Blood DNA was isolated from 200 μl heparinised blood
sample using QIAamp DNA mini kit (Qiagen, Crawley,
UK) according to the manufacturer’s instruction, except
that the DNA was eluted with 50 μl Buffer AE and incu-
bated at 65°C for 5 minutes before centrifugation. The
DNA was stored at −20°C until further use. The aliquots
of DNA preparation were run on a 1% agarose gel,
stained with ethidium bromide and visualized by UV
transllumination. The DNA concentration was deter-
mined by UV spectrometry.
Digestion of human blood DNA with micrococcal
nuclease
0.5 μg human blood DNA was mixed with 103 gel units
of micrococcal nuclease (New England Biolab, Herts,
UK) in 20 μl reaction volume containing 1 μM CaCl2 and
0, 1%, 3%, 5%, 7% or 9% ox bile. Following incubation at
room temperature for 10 minutes, the reaction mixture
Figure 1 The format and principle of the selective target DNA enrichment method.
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was run on a 1% agarose gel, stained with ethidium
bromide, and photographed under UV illuminator.
Selective Salmonella Typhi target DNA enrichment and
preparation
A flow diagram of two selective target DNA enrichment
methods (STEM1 and STEM2) used in this study for en-
richment of Salmonella Typhi bacterial DNA from
spiked blood samples was shown in Figure 1.
In STEM1, 200 μl spiked blood sample was gently
mixed with equal volume of 10% ox bile (Oxgall, BD
Biosciences, Oxford, UK), incubated at room tempera-
ture for 10 minutes, and then centrifuged at 13,000
RPM for 5 minutes. The pellet was re-suspended in
100 μl 0.1 μM CaCl2, and 1 μl (10
3 gel units) micrococ-
cal nuclease was added. The mixture was incubated at
37°C for 10 minutes and then centrifuged again at 13,000
RPM for 5 minutes. The pellet contained the enriched
Salmonella Typhi bacteria and was re-suspended in
200 μl phosphate buffered saline (PBS) for bacterial
DNA isolation.
In STEM2, 200 μl spiked blood was mixed together
with 200 μl of 10% ox bile, 4 μl of 0.1 mM CaCl2 and 2 μl
(2×103 gel units) micrococcal nuclease, incubated at
room temperature for 20 minutes, and then centrifuged
at 13,000 RPM for 5 minutes to collect the pellet
containing enriched bacterial cells. The pellet was re-
suspended in 200 μl PBS for bacterial DNA isolation.
Following the re-suspension of the enriched bacterial
pellet obtained in STEM1 or STEM2, bacterial DNA
was isolated using QIAamp DNA mini kit in the same
way as described in the section of Conventional DNA
preparation above, except that the mixture of 20 μl pro-
teinase K solution and bacterial pellet suspension was
incubated for 5 minutes at room temperature to com-
pletely remove any residual activity of micrococcal
nuclease before Buffer AL was added.
PCR primers of Salmonella serovar Typhi Quailes strain
The PCR primers for Salmonella serovar Typhi Quailes
strain were designed according to the fliC-d gene
sequence of Salmonella serovar Typhi (Accession
number L21912): H-for (ACTCAGGCTTCCCGTAACGC)
and Hd-rev (GGCTAGTATTGTCCTTATCGG) [15],
and synthesized by Sigma Genosys (Sigma-Aldrich,
Dorset, England).
PCR protocol
The PCR reaction was carried out in a 50 μl volume,
comprising 0.5 U of Taq DNA polymerase (Qiagen,
Crawley, UK), 1 x Qiagen PCR buffer, 1.5 mM magnesium
chloride, 200 μM concentrations of each deoxynucleoside
triphosphate, 0.5 μM concentrations of the primers H-for
and Hd-rev, and 10 μl of DNA template. The following
amplification steps were used: 1 cycle of 95°C for 5 min;
35 cycles of 93°C for 30 sec, 55°C for 30 sec, and 72°C for
40 sec; and 1 cycle of 72°C for 5 min. The PCR amplifica-
tion product was separated by electrophoresis on a 1%
agarose gel, stained with ethidium bromide, and photo-
graphed by a UV transilluminator.
Results
Micrococcal nuclease is active on human DNA in the
presence of ox bile
Human blood DNA was incubated with micrococcal
nuclease at different concentrations of ox bile. The
extent of digestion of human DNA by micrococcal
nuclease was compared, as shown in Figure 2. The result
showed that micrococcal nuclease remained active at the
bile concentration up to 9%.
Selective target DNA enrichment methods reduce the
background human DNA prepared from blood samples
DNA prepared by the 2 different STEMs was compared
with that isolated through the conventional method
from blood samples spiked with Salmonella Typhi, as
shown in Figure 3. There was a high background caused
by human DNA in the preparations made through the
conventional method (lanes 8–14), but not in the pre-
parations made by STEM1 (lanes 1–7). Similar results
were also obtained with STEM2 (data not shown).
PCR sensitivity for detection of Salmonella Typhi is
enhanced through the selective removal of background
human DNA from blood samples
The sensitivity of PCR was compared using DNA
prepared by STEM and by conventional methods from
Figure 2 Digestion of human blood DNA with micrococcal
nuclease at different concentration of ox bile. Lane 1: DNA
molecular marker; Lane 2: No micrococcal nuclease and no ox bile;
Lanes 3–8: 0%, 1%, 3%, 5%, 7% and 9% ox bile concentration
respectively.
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the spiked blood samples. Figure 4 shows the fliC-d
amplicons from the different DNA preparations. Using
the DNA prepared with the conventional method, the
fliC-d amplicons were only seen in the sample with
3x105 CFU per millilitre of blood (equivalent to approxi-
mately 6,000 CFU per PCR). However, the fliC-d ampli-
cons were seen in all the samples with 3x105, 3x104,
3x103 and 3x102 CFU per millilitre of blood, with high-
est sensitivity equal to approximately 6 CFU per PCR
reaction. Independent experiments consistently found
that STEM enhanced PCR sensitivity by 1,000 fold
through selective removal of background human DNA
in the spiked blood samples.
Discussion
We describe a novel method (STEM) that enhances
detection of Salmonella Typhi in spiked blood speci-
mens. Using this method we were able to show a sub-
stantial reduction in dominating human background
DNA in clinical samples and consequently increased the
sensitivity of PCR detection of Salmonella Typhi from
blood samples by 1,000 fold.
Early diagnosis and prompt treatment are essential for
optimal management of typhoid patients, and therefore
a sensitive and specific PCR assay is useful. Although
many Salmonella Typhi PCR-based assays were studied
in last decades, none has been brought to clinical use
due to the limitations caused by low bactereamic level in
typhoid patients. PCR sensitivity is directly related to the
actual number of colony forming units found in the
blood [3]. Typical clinical typhoid samples have <1 bac-
teria/ml of blood [11,19]. As a result, PCR offers only
limited potential for typhoid diagnostics unless a new
sample preparation method is developed. A DNA or
bacterial capture system or even a culture enrichment
step prior to amplification could improve PCR sensitiv-
ity. Using a culture enrichment step prior to amplifica-
tion Teh et al. demonstrated that the 5 hour broth
culture enrichment improved PCR sensitivity by 10
times for spiked blood, and 100 times for spiked stool
samples [23]. We have recently developed a blood cul-
ture PCR assay which could detect as few as 0.75 bac-
teria per millilitre of blood following 3 hours of culture
enrichment [22]. But like conventional blood culture,
the PCR assay following bacterial culture enrichment
still has some practical limitations including availability
of culture facilities in disease endemic areas and bacteria
being unculturable due to the use of antibiotics. There-
fore, a PCR assay method that can be used directly on
clinical blood samples is still a better choice. Collecting
and then extracting DNA from a large volume of blood
may theoretically improve PCR assays, but the presence
of dominating human DNA causes false-positive PCR
signals due to the non-specific binding of primers and
Figure 3 DNA preparations made by STEM1 and the conventional method. M: DNA marker; 1–7: DNA prepared by the STEM1; 8–14: DNA
prepared by the conventional method. Lanes 1 and 8, 2 and 9, 3 and 10, 4 and 11, 5 and 12, 6 and 13, 7 and 14: DNA prepared from the spiked
blood samples containing 3x105, 3x104, 3x103, 3x102, 30 , 3, 0 CFU/ml of Salmonella Typhi, respectively.
Figure 4 Comparison of PCR sensitivities between the DNA preparations. Salmonella serovar Typhi fliC-d amplicons (763 bp) amplified by
PCR using different DNA preparations were separated on a 1% agarose gel. M: DNA marker; P: Salmonella Typhi DNA positive control; N: No DNA
negative control; Lanes 1–7: PCR on DNA prepared by STEM1; Lanes 8–14; PCR on DNA prepared by the conventional method. Lanes 1 and 8, 2
and 9, 3 and 10, 4 and 11, 5 and 12, 6 and 13, 7 and 14: DNA prepared from the spiked blood samples containing 3×105, 3×104, 3×103, 3×102,
30, 3, 0 CFU/ml of Salmonella Typhi, respectively.
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false-negative results due to reduced sensitivity. Cur-
rently two protocols have been commercially marketed
for reducing the presence of dominating human DNA:
MolYsis (Molzym GmbH & Co. KG, Bremen, Germany)
and Pureprove (SIRS-Lab GmbH, Jena, Germany). The
former uses a chaotropic buffer containing guanidine
hydrochloride to selectively lyze human cells. The
released eukaryotic DNA was subsequently degraded by
the addition of a chaotropic resistant nuclease, and the
intact bacterial cells were collected for bacterial DNA
purification. For the latter, total genomic (i.e. human and
bacterial) DNA is first conventionally extracted specific
bacterial genomic DNA is then isolated using a DNA
binding protein that recognizes unmethylated CpG
motifs predominantly present in bacterial and fungal
genomes at significantly lower frequencies than in human
genomes. Horz et al. recently compared these two pro-
tocols for DNA preparation, and found that both were
able to substantially reduce the human background
DNA in most of the cases but loss of bacterial DNA was
also a problem [24]. For example, with MolYsis the
recovery of P. gingivalis in periodontal samples was less
than 20%. As mentioned above, the MolYsis protocol
uses a guanidine hydrochloride chaotropic buffer for
lysis of human/animal cells, and bacteria with a thin or
labile cell wall (e.g. members of the genus Treponema)
or those exposed to cell wall-active antibiotics and/or
human immunosystems or bacteria even devoid of a cell
wall (e.g. Mycoplasma, Chlamydia) are also lyzed. There-
fore, the MolYsis protocol may not be suitable for use in
the diagnosis of Gram-negative sepsis. They also found,
on the other hand, the Pureprove technology was not
efficient in removal of human DNA. This is because it is
based on selective binding of bacterial DNA to a DNA
binding protein that recognizes unmethylated CpG motifs.
CpG islands and motifs are not distributed equally
over the entire human genome, and fragments without
any 5′-methylcytosin are present in every preparation
and will mix with prokaryotic DNA. In addition, as
cytosine methylation is negatively correlated with gene
expression, in regions of active genes the CpG
dinucleotides-motifs are also de-methylated and, if frag-
mentized, could possibly mix with prokaryotic DNA as
well. It should be emphasized that in Horz et al. study,
the mean absolute bacterial gene copy numbers was
2.23×1010 (saliva and supragingival plaque collected by
cotton tampon) and 1.37x1010 (pooled subgingivalsulcus
fluid) [24]. Such a high level of bacterial template in a
blood sample from a patient with typhoid is unlikely.
Therefore, the fact that typical clinical typhoid samples
contain <1 organism/ml of blood highlights the big chal-
lenges faced for developing PCR diagnostics for typhoid.
Bile is a widely used ingredient in culture media for
blood culture and the bile resistance of Salmonella is
well-known. This could be exploited for developing
typhoid diagnostics as bile can selectively lyze human
blood cells and release both human DNA and intracellu-
lar bacteria without damaging bacterial cells [22,25]. In
the present study, we have investigated the use of ox bile
and micrococcal nuclease for selective lysis of blood cells
and removal of background human DNA. We tested the
use of micrococcal nuclease for removal of the released
human DNA in the presence and absence of ox bile, and
found that micrococcal nuclease is bile resistant and ac-
tive at a wide range of bile concentrations used up to
9%. This suggests that micrococcal nuclease could be
used to degrade human DNA while ox bile is added for
the lysis of blood cells, potentially simplifying the design
of typhoid diagnostics. We have tried two STEM proto-
cols for removal of background human DNA and con-
firmed that both methods can substantially reduce
background human DNA in the DNA preparations. As a
result, the percentage of bacterial DNA in the prepar-
ation was increased. When the DNA prepared by STEM
was used for PCR assay, we have consistently found that
PCR sensitivity increased by at least 1,000 fold, com-
pared with that using conventionally prepared DNA
(which contained a large amount of background human
DNA). These promising results indicate that STEM
should now be investigated in field trials and to this end
the approach is currently being applied in an endemic
setting. Although the present study aims to improve
current diagnostics for typhoid, the method described
herein can be generally applied to sample preparation
for diagnosis of infections with other ox bile resistant
bacterial and fungal pathogens, in particular, where the
low level of a pathogen presents a problem for current
molecular diagnostics.
In conclusion, we describe herein a novel method,
which we have termed “the selective target DNA enrich-
ment method” (STEM). STEM can enrich bacteria from
large volume samples, remove background human DNA,
and enhance the sensitivity of PCR detection for
Salmonella Typhi in blood samples. Therefore, this novel
method of sample preparation offers a better option for
improved typhoid PCR assays directly using clinical
specimens in diagnosis of this globally important infec-
tion disease which we believe could be of importance in
improving clinical care and providing effective evalu-
ation of novel vaccines.
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